| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleosomal DNA binding | 3.77e-08 | 67 | 150 | 8 | GO:0031492 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | FOXO3 XBP1 H2AC21 AHDC1 HNRNPC H2AC6 H2AC18 H2AC20 H2AC1 H2AX H2AJ | 5.50e-08 | 167 | 150 | 11 | GO:0031490 |
| GeneOntologyMolecularFunction | nucleosome binding | 7.47e-07 | 98 | 150 | 8 | GO:0031491 | |
| GeneOntologyMolecularFunction | structural constituent of chromatin | 1.05e-05 | 100 | 150 | 7 | GO:0030527 | |
| GeneOntologyMolecularFunction | chromatin binding | FOXO3 POLE XBP1 H2AC21 CHD2 AHDC1 HNRNPC NCOR1 H2AC6 H2AC18 H2AC20 H2AC1 H2AX H2AJ NFAT5 CUX1 | 1.43e-04 | 739 | 150 | 16 | GO:0003682 |
| GeneOntologyMolecularFunction | chromatin-protein adaptor activity | 2.50e-04 | 41 | 150 | 4 | GO:0140463 | |
| GeneOntologyBiologicalProcess | heterochromatin formation | H2AC21 TRIP12 H2AC6 H2AC18 H2AC20 KMT2D UBR5 H2AC1 H2AX MAEL H2AJ | 3.55e-08 | 163 | 152 | 11 | GO:0031507 |
| GeneOntologyBiologicalProcess | chromatin organization | UIMC1 BRPF3 EYA4 TOPBP1 H2AC21 DAXX CHD2 TRIP12 MIER1 HNRNPC PRDM2 RSBN1 NCOR1 H2AC6 H2AC18 H2AC20 KMT2D UBR5 H2AC1 MDC1 H2AX MAEL H2AJ NFAT5 | 4.15e-08 | 896 | 152 | 24 | GO:0006325 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | UIMC1 BRPF3 EYA4 WNT10B TOPBP1 H2AC21 DAXX CHD2 TRIP12 MIER1 HNRNPC PRDM2 RSBN1 NCOR1 H2AC6 H2AC18 H2AC20 KMT2D UBR5 H2AC1 MDC1 H2AX MAEL H2AJ NFAT5 | 7.79e-08 | 999 | 152 | 25 | GO:0071824 |
| GeneOntologyBiologicalProcess | negative regulation of gene expression, epigenetic | H2AC21 TRIP12 H2AC6 H2AC18 H2AC20 KMT2D UBR5 H2AC1 H2AX MAEL H2AJ | 3.31e-07 | 203 | 152 | 11 | GO:0045814 |
| GeneOntologyBiologicalProcess | chromatin remodeling | UIMC1 BRPF3 H2AC21 DAXX CHD2 TRIP12 MIER1 HNRNPC PRDM2 RSBN1 H2AC6 H2AC18 H2AC20 KMT2D UBR5 H2AC1 H2AX MAEL H2AJ NFAT5 | 5.57e-07 | 741 | 152 | 20 | GO:0006338 |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | H2AC21 TRIP12 H2AC6 H2AC18 H2AC20 KMT2D UBR5 H2AC1 H2AX MAEL H2AJ | 3.47e-05 | 330 | 152 | 11 | GO:0040029 |
| GeneOntologyBiologicalProcess | heterochromatin boundary formation | 5.40e-05 | 2 | 152 | 2 | GO:0033696 | |
| GeneOntologyCellularComponent | nucleosome | 7.13e-05 | 138 | 153 | 7 | GO:0000786 | |
| GeneOntologyCellularComponent | Golgi cis cisterna | 9.57e-05 | 33 | 153 | 4 | GO:0000137 | |
| GeneOntologyCellularComponent | XY body | 6.11e-04 | 23 | 153 | 3 | GO:0001741 | |
| GeneOntologyCellularComponent | Golgi cisterna membrane | 6.40e-04 | 94 | 153 | 5 | GO:0032580 | |
| GeneOntologyCellularComponent | spindle | CCSAP CLASP1 TOPBP1 CDCA8 GOLGA8N NCOR1 MAP7D1 MTCL1 MZT2B GOLGA8O ESPL1 | 7.16e-04 | 471 | 153 | 11 | GO:0005819 |
| Domain | HISTONE_H2A | 1.98e-10 | 21 | 150 | 7 | PS00046 | |
| Domain | Histone_H2A | 4.12e-10 | 23 | 150 | 7 | IPR002119 | |
| Domain | H2A | 4.12e-10 | 23 | 150 | 7 | SM00414 | |
| Domain | Histone_H2A_CS | 1.14e-09 | 15 | 150 | 6 | IPR032458 | |
| Domain | Histone_H2A_C | 2.79e-09 | 17 | 150 | 6 | IPR032454 | |
| Domain | Histone_H2A_C | 2.79e-09 | 17 | 150 | 6 | PF16211 | |
| Domain | Histone_H2A/H2B/H3 | 3.12e-07 | 56 | 150 | 7 | IPR007125 | |
| Domain | Histone | 3.12e-07 | 56 | 150 | 7 | PF00125 | |
| Domain | Histone-fold | 4.67e-06 | 83 | 150 | 7 | IPR009072 | |
| Domain | - | 1.92e-05 | 69 | 150 | 6 | 1.10.20.10 | |
| Domain | AIP3_C | 6.41e-05 | 2 | 150 | 2 | IPR022782 | |
| Domain | SprT | 6.41e-05 | 2 | 150 | 2 | SM00731 | |
| Domain | SprT-like | 6.41e-05 | 2 | 150 | 2 | PF10263 | |
| Domain | AIP3 | 6.41e-05 | 2 | 150 | 2 | PF03915 | |
| Domain | SprT-like_domain | 6.41e-05 | 2 | 150 | 2 | IPR006640 | |
| Domain | RUN | 3.79e-04 | 18 | 150 | 3 | SM00593 | |
| Domain | GOLGA2L5 | 3.79e-04 | 18 | 150 | 3 | PF15070 | |
| Domain | Golgin_A | 3.79e-04 | 18 | 150 | 3 | IPR024858 | |
| Domain | RUN | 4.48e-04 | 19 | 150 | 3 | PS50826 | |
| Domain | RUN | 4.48e-04 | 19 | 150 | 3 | PF02759 | |
| Domain | BRCT | 4.48e-04 | 19 | 150 | 3 | PF00533 | |
| Domain | Run_dom | 4.48e-04 | 19 | 150 | 3 | IPR004012 | |
| Domain | - | 6.99e-04 | 22 | 150 | 3 | 2.130.10.30 | |
| Domain | EPHD | 6.99e-04 | 22 | 150 | 3 | PS51805 | |
| Domain | BRCT | 6.99e-04 | 22 | 150 | 3 | SM00292 | |
| Domain | - | 7.99e-04 | 23 | 150 | 3 | 3.40.50.10190 | |
| Domain | RCC1/BLIP-II | 7.99e-04 | 23 | 150 | 3 | IPR009091 | |
| Domain | 2FE2S_FER_2 | 9.41e-04 | 6 | 150 | 2 | PS51085 | |
| Domain | 2Fe-2S_ferredoxin-type | 9.41e-04 | 6 | 150 | 2 | IPR001041 | |
| Domain | Fer2 | 9.41e-04 | 6 | 150 | 2 | PF00111 | |
| Domain | BRCT | 1.15e-03 | 26 | 150 | 3 | PS50172 | |
| Domain | Laminin_G | 1.21e-03 | 58 | 150 | 4 | IPR001791 | |
| Domain | HECT | 1.29e-03 | 27 | 150 | 3 | PF00632 | |
| Domain | HECTc | 1.29e-03 | 27 | 150 | 3 | SM00119 | |
| Domain | HECT_dom | 1.29e-03 | 27 | 150 | 3 | IPR000569 | |
| Domain | HECT | 1.29e-03 | 27 | 150 | 3 | PS50237 | |
| Domain | BRCT_dom | 1.44e-03 | 28 | 150 | 3 | IPR001357 | |
| Pathway | REACTOME_METALLOPROTEASE_DUBS | 1.73e-09 | 29 | 108 | 7 | MM15291 | |
| Pathway | REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE | 1.11e-07 | 31 | 108 | 6 | MM17225 | |
| Pathway | REACTOME_CELL_CYCLE | UIMC1 CLASP1 POLE TOPBP1 DAXX CDCA8 GOLGA8N H2AC6 H2AC18 H2AC20 MDC1 CEP41 H2AX TAOK1 CEP131 H2AJ MZT2B GOLGA8O ESPL1 | 1.39e-07 | 603 | 108 | 19 | MM14635 |
| Pathway | REACTOME_METALLOPROTEASE_DUBS | 3.37e-07 | 37 | 108 | 6 | M27580 | |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | 5.46e-07 | 40 | 108 | 6 | MM14936 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 9.80e-07 | 44 | 108 | 6 | MM15527 | |
| Pathway | REACTOME_M_PHASE | CLASP1 CDCA8 GOLGA8N H2AC6 H2AC18 H2AC20 CEP41 H2AX TAOK1 CEP131 H2AJ MZT2B GOLGA8O ESPL1 | 1.47e-06 | 387 | 108 | 14 | MM15364 |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | 2.15e-06 | 78 | 108 | 7 | M27234 | |
| Pathway | REACTOME_DNA_REPAIR | UIMC1 EYA4 POLE TOPBP1 H2AC6 H2AC18 H2AC20 MDC1 H2AX H2AJ SPRTN REV1 | 3.23e-06 | 301 | 108 | 12 | MM15433 |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | 3.76e-06 | 55 | 108 | 6 | MM14932 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | BRPF3 H2AC21 NCOR1 H2AC6 H2AC18 H2AC20 KMT2D H2AC1 H2AX H2AJ ELP4 | 7.43e-06 | 272 | 108 | 11 | M29619 |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | 8.62e-06 | 37 | 108 | 5 | MM14883 | |
| Pathway | REACTOME_DNA_REPAIR | UIMC1 EYA4 POLE TOPBP1 H2AC6 H2AC18 H2AC20 MDC1 H2AX H2AJ SPRTN REV1 | 8.78e-06 | 332 | 108 | 12 | M15434 |
| Pathway | REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION | 9.87e-06 | 38 | 108 | 5 | MM15434 | |
| Pathway | KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS | 1.12e-05 | 139 | 108 | 8 | M4741 | |
| Pathway | REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA | 1.13e-05 | 39 | 108 | 5 | MM14850 | |
| Pathway | REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE | 1.20e-05 | 67 | 108 | 6 | M39003 | |
| Pathway | REACTOME_BASE_EXCISION_REPAIR | 1.20e-05 | 67 | 108 | 6 | MM15429 | |
| Pathway | REACTOME_CELL_CYCLE | UIMC1 CLASP1 POLE TOPBP1 DAXX CDCA8 H2AC6 H2AC18 H2AC20 MDC1 CEP41 H2AX TAOK1 CEP131 H2AJ MZT2B ESPL1 | 1.99e-05 | 694 | 108 | 17 | M543 |
| Pathway | REACTOME_TELOMERE_MAINTENANCE | 2.13e-05 | 74 | 108 | 6 | MM14605 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 2.67e-05 | 114 | 108 | 7 | MM15361 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | WIPF1 CLASP1 CDCA8 H2AC6 LIMK1 H2AC18 H2AC20 WASF2 H2AX TAOK1 H2AJ | 3.68e-05 | 323 | 108 | 11 | M27080 |
| Pathway | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | 3.87e-05 | 50 | 108 | 5 | MM15308 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 4.14e-05 | 122 | 108 | 7 | M29689 | |
| Pathway | REACTOME_UCH_PROTEINASES | 5.37e-05 | 87 | 108 | 6 | MM15287 | |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | 5.64e-05 | 54 | 108 | 5 | MM14904 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 5.89e-05 | 175 | 108 | 8 | MM14941 | |
| Pathway | REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE | 6.17e-05 | 55 | 108 | 5 | M29526 | |
| Pathway | REACTOME_BASE_EXCISION_REPAIR | 6.50e-05 | 90 | 108 | 6 | M2158 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 6.73e-05 | 56 | 108 | 5 | MM17236 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 6.91e-05 | 91 | 108 | 6 | M27101 | |
| Pathway | REACTOME_M_PHASE | CLASP1 CDCA8 H2AC6 H2AC18 H2AC20 CEP41 H2AX TAOK1 CEP131 H2AJ MZT2B ESPL1 | 8.22e-05 | 417 | 108 | 12 | M27662 |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | 8.29e-05 | 94 | 108 | 6 | M27230 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 9.06e-05 | 138 | 108 | 7 | M29805 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 9.32e-05 | 96 | 108 | 6 | M27792 | |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 1.08e-04 | 142 | 108 | 7 | M27233 | |
| Pathway | REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION | 1.10e-04 | 62 | 108 | 5 | M27700 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | WIPF1 CLASP1 GOLGA8R ARHGEF17 CDCA8 HNRNPC ZNF512B H2AC6 LIMK1 H2AC18 H2AC20 WASF2 H2AX TAOK1 H2AJ ARHGAP19 | 1.14e-04 | 720 | 108 | 16 | M41838 |
| Pathway | REACTOME_DNA_METHYLATION | 1.28e-04 | 64 | 108 | 5 | M27429 | |
| Pathway | REACTOME_CHROMOSOME_MAINTENANCE | 1.30e-04 | 102 | 108 | 6 | MM15430 | |
| Pathway | REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH | 1.45e-04 | 104 | 108 | 6 | M29829 | |
| Pathway | REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3 | 1.48e-04 | 66 | 108 | 5 | M27488 | |
| Pathway | REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION | 1.59e-04 | 67 | 108 | 5 | M27342 | |
| Pathway | REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION | 1.71e-04 | 68 | 108 | 5 | M27658 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_THE_HUMAN_SILENCING_HUB_HUSH_COMPLEX | 1.96e-04 | 70 | 108 | 5 | M48261 | |
| Pathway | REACTOME_CHROMATIN_MODIFICATIONS_DURING_THE_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | 1.96e-04 | 70 | 108 | 5 | M48028 | |
| Pathway | REACTOME_TELOMERE_MAINTENANCE | 2.18e-04 | 112 | 108 | 6 | M4052 | |
| Pathway | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | 2.24e-04 | 72 | 108 | 5 | M29714 | |
| Pathway | REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA | 2.24e-04 | 72 | 108 | 5 | M27132 | |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | 2.39e-04 | 73 | 108 | 5 | M27166 | |
| Pathway | REACTOME_HCMV_INFECTION | 2.45e-04 | 162 | 108 | 7 | M29804 | |
| Pathway | REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION | 2.71e-04 | 75 | 108 | 5 | M27343 | |
| Pathway | REACTOME_MEIOTIC_SYNAPSIS | 3.26e-04 | 78 | 108 | 5 | M1061 | |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | 3.45e-04 | 79 | 108 | 5 | M27191 | |
| Pathway | REACTOME_CELL_CYCLE_MITOTIC | CLASP1 POLE CDCA8 H2AC6 H2AC18 H2AC20 CEP41 H2AX TAOK1 CEP131 H2AJ MZT2B ESPL1 | 3.52e-04 | 561 | 108 | 13 | M5336 |
| Pathway | REACTOME_MEIOTIC_RECOMBINATION | 5.69e-04 | 88 | 108 | 5 | M1011 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS | 5.99e-04 | 89 | 108 | 5 | M27943 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 6.02e-04 | 246 | 108 | 8 | M10189 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 6.17e-04 | 136 | 108 | 6 | MM14848 | |
| Pathway | REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE | 6.30e-04 | 90 | 108 | 5 | M27691 | |
| Pathway | REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION | 6.30e-04 | 90 | 108 | 5 | M29668 | |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | 6.61e-04 | 191 | 108 | 7 | MM15289 | |
| Pathway | REACTOME_CHROMOSOME_MAINTENANCE | 6.93e-04 | 139 | 108 | 6 | M868 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 6.93e-04 | 139 | 108 | 6 | M715 | |
| Pathway | WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME | 6.93e-04 | 23 | 108 | 3 | M39883 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | 7.32e-04 | 93 | 108 | 5 | M27487 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | 8.86e-04 | 97 | 108 | 5 | M48262 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | 8.96e-04 | 146 | 108 | 6 | MM15292 | |
| Pathway | REACTOME_DEUBIQUITINATION | 9.08e-04 | 262 | 108 | 8 | MM15286 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | 9.42e-04 | 57 | 108 | 4 | MM15298 | |
| Pathway | REACTOME_UCH_PROTEINASES | 1.11e-03 | 102 | 108 | 5 | M27576 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.14e-03 | 153 | 108 | 6 | MM15522 | |
| Pathway | REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | 1.27e-03 | 105 | 108 | 5 | M27425 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.32e-03 | 106 | 108 | 5 | M27458 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_KRAB_ZFP_PROTEINS | 1.38e-03 | 107 | 108 | 5 | M48260 | |
| Pathway | REACTOME_DNA_REPLICATION_PRE_INITIATION | 1.39e-03 | 159 | 108 | 6 | M27665 | |
| Pathway | REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | 1.43e-03 | 108 | 108 | 5 | M27426 | |
| Pathway | WP_INSULIN_SIGNALING | 1.44e-03 | 160 | 108 | 6 | MM15956 | |
| Pathway | WP_INSULIN_SIGNALING | 1.44e-03 | 160 | 108 | 6 | M39482 | |
| Pathway | PID_ERA_GENOMIC_PATHWAY | 1.45e-03 | 64 | 108 | 4 | M200 | |
| Pathway | REACTOME_AMYLOID_FIBER_FORMATION | 1.56e-03 | 110 | 108 | 5 | M27958 | |
| Pathway | REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION | 1.56e-03 | 110 | 108 | 5 | M27696 | |
| Pathway | WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME | 1.58e-03 | 8 | 108 | 2 | M42528 | |
| Pathway | REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP | 1.62e-03 | 111 | 108 | 5 | M27187 | |
| Pathway | WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP | 1.68e-03 | 112 | 108 | 5 | M48334 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | 1.95e-03 | 170 | 108 | 6 | M27582 | |
| Pathway | REACTOME_HOMOLOGY_DIRECTED_REPAIR | 1.97e-03 | 116 | 108 | 5 | MM15294 | |
| Pathway | REACTOME_HCMV_LATE_EVENTS | 1.97e-03 | 116 | 108 | 5 | M29806 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 2.20e-03 | 119 | 108 | 5 | M607 | |
| Pathway | REACTOME_CELLULAR_SENESCENCE | 2.20e-03 | 119 | 108 | 5 | MM14901 | |
| Pathway | PID_ATM_PATHWAY | 2.20e-03 | 34 | 108 | 3 | M84 | |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | 2.25e-03 | 72 | 108 | 4 | MM15381 | |
| Pathway | REACTOME_MEIOSIS | 2.28e-03 | 120 | 108 | 5 | M529 | |
| Pathway | REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS | 2.61e-03 | 75 | 108 | 4 | MM15299 | |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | 2.72e-03 | 125 | 108 | 5 | M27186 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | 3.01e-03 | 78 | 108 | 4 | M27589 | |
| Pathway | REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | 3.02e-03 | 128 | 108 | 5 | M48019 | |
| Pathway | WP_NAD_METABOLISM_SIRTUINS_AND_AGING | 3.06e-03 | 11 | 108 | 2 | M39439 | |
| Pathway | REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS | 3.12e-03 | 129 | 108 | 5 | M27795 | |
| Pathway | REACTOME_DNA_REPLICATION | 3.15e-03 | 187 | 108 | 6 | M1017 | |
| Pubmed | CTTNBP2 DSCAM CLASP1 NBEA GRIK3 SORBS1 KANK2 PPM1H GOLGA8N KIF7 NCOR1 MAP7D1 CELSR2 UBR5 WASF2 KIAA1217 ZNF516 ALYREF CEP131 DIXDC1 MTCL1 GOLGA8O CEP170B MOB4 CUX1 RAI1 | 2.91e-13 | 963 | 158 | 26 | 28671696 | |
| Pubmed | DNA damage triggers nucleotide excision repair-dependent monoubiquitylation of histone H2A. | 8.21e-10 | 11 | 158 | 5 | 16702407 | |
| Pubmed | 8.21e-10 | 11 | 158 | 5 | 15078818 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FOXO3 MYO1E SZT2 POLE STK11IP AHDC1 PCNX2 PIKFYVE NCOR1 EHBP1L1 KMT2D CELSR3 PTPRF CELSR2 SGSM2 NEK8 ZNF516 CEP131 ESPL1 ADAT1 CEP170B RAI1 ZNF687 | 1.27e-09 | 1105 | 158 | 23 | 35748872 |
| Pubmed | Deimination of histone H2A and H4 at arginine 3 in HL-60 granulocytes. | 2.27e-09 | 13 | 158 | 5 | 15823041 | |
| Pubmed | 7.17e-09 | 88 | 158 | 8 | 26318153 | ||
| Pubmed | 7.62e-09 | 16 | 158 | 5 | 15386022 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | RPL34 MYO1E CLASP1 EPS8L1 KANK2 TRIP12 HNRNPC MAP7D1 CELSR3 MDC1 MTCL1 MZT2B REV1 | 1.25e-08 | 361 | 158 | 13 | 26167880 |
| Pubmed | Phosphorylation of histone H2A inhibits transcription on chromatin templates. | 1.48e-08 | 18 | 158 | 5 | 15010469 | |
| Pubmed | Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. | 2.01e-08 | 19 | 158 | 5 | 16359901 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | UIMC1 C14orf93 HIF1A RPL34 EYA4 CHERP ZSCAN5A TOPBP1 CHD2 TRIP12 MIER1 AHDC1 HNRNPC PRDM2 ZNF512B NCOR1 MAP7D1 KMT2D MDC1 ALYREF CUX1 RAI1 ZNF687 | 2.41e-08 | 1294 | 158 | 23 | 30804502 |
| Pubmed | Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA. | 2.98e-08 | 69 | 158 | 7 | 11689053 | |
| Pubmed | 4.43e-08 | 73 | 158 | 7 | 14657027 | ||
| Pubmed | 4.43e-08 | 73 | 158 | 7 | 9566873 | ||
| Pubmed | 4.87e-08 | 74 | 158 | 7 | 36180920 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXS1 FOXO3 FOXO3B EYA4 POLE SLU7 KANK2 TRIP12 KIF7 NCOR1 MAP7D1 KMT2D UBR5 WASF2 ALYREF CUX1 HERC5 NOVA1 | 8.02e-08 | 857 | 158 | 18 | 25609649 |
| Pubmed | 8.43e-08 | 10 | 158 | 4 | 19766185 | ||
| Pubmed | 1.39e-07 | 86 | 158 | 7 | 11080476 | ||
| Pubmed | FOXO3 JCAD CTTNBP2 CLASP1 SORBS1 PPM1H KIF7 UBR5 AMOTL1 CEP131 MTCL1 CEP170B MOB4 | 1.47e-07 | 446 | 158 | 13 | 24255178 | |
| Pubmed | BRPF3 SZT2 TOPBP1 SRCIN1 MIER1 ZNF512B CELSR3 MDC1 ZNF516 DIXDC1 FAM149B1 ESPL1 RAI1 ZNF687 | 1.55e-07 | 529 | 158 | 14 | 14621295 | |
| Pubmed | JCAD POLE SLU7 NBEA CHD2 KIF7 ANKRD36B NCOR1 EHBP1L1 KMT2D ZNF516 MTCL1 CUX1 RAI1 ZNF687 | 2.50e-07 | 638 | 158 | 15 | 31182584 | |
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | MYO1E COL27A1 KIF7 H2AC20 MAP7D1 STXBP3 ZNF516 ALYREF NFAT5 CEP170B CUX1 | 2.81e-07 | 321 | 158 | 11 | 32098917 |
| Pubmed | 2.84e-07 | 13 | 158 | 4 | 29499138 | ||
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 6.54e-07 | 157 | 158 | 8 | 30686591 | |
| Pubmed | Nuclear High Mobility Group A2 (HMGA2) Interactome Revealed by Biotin Proximity Labeling. | 7.04e-07 | 37 | 158 | 5 | 36835656 | |
| Pubmed | 9.14e-07 | 5 | 158 | 3 | 21622030 | ||
| Pubmed | 1.14e-06 | 117 | 158 | 7 | 12107410 | ||
| Pubmed | SELENOT CHERP CLASP1 SYTL2 HMOX1 KANK2 PIKFYVE STXBP3 MDC1 AMOTL1 CEP131 MZT2B ESPL1 ELP4 ZNF687 | 1.42e-06 | 733 | 158 | 15 | 34672954 | |
| Pubmed | MDC1 collaborates with TopBP1 in DNA replication checkpoint control. | 1.82e-06 | 6 | 158 | 3 | 21482717 | |
| Pubmed | 1.82e-06 | 6 | 158 | 3 | 15509584 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | FOXO3 JCAD CCDC8 CLASP1 SORBS1 ARHGEF17 TRIP12 PPM1H RUSC2 LIMK1 MAP7D1 KIAA1217 CEP131 MTCL1 CEP170B ARHGAP19 | 2.17e-06 | 861 | 158 | 16 | 36931259 |
| Pubmed | 2.31e-06 | 21 | 158 | 4 | 24483844 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | UIMC1 CLASP1 DAXX TRIP12 MIER1 HNRNPC PRDM2 NCOR1 KMT2D MDC1 ZNF516 EIF2B5 TAOK1 ESPL1 ZNF687 | 2.76e-06 | 774 | 158 | 15 | 15302935 |
| Pubmed | CLASP1 SORBS1 ARHGEF17 RUSC2 RSBN1 MAP7D1 UBR5 SGSM2 MTCL1 NFAT5 CEP170B | 2.85e-06 | 407 | 158 | 11 | 12693553 | |
| Pubmed | Characterization of the 55-kb mouse histone gene cluster on chromosome 3. | 3.18e-06 | 7 | 158 | 3 | 8858345 | |
| Pubmed | RNF168 ubiquitinates K13-15 on H2A/H2AX to drive DNA damage signaling. | 3.18e-06 | 7 | 158 | 3 | 22980979 | |
| Pubmed | Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells. | 3.18e-06 | 7 | 158 | 3 | 16699504 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | UIMC1 CLASP1 TOPBP1 DAXX SORBS1 PIKFYVE NCOR1 UBR5 KIAA1217 ZNF516 CEP131 SPRTN CEP170B | 3.20e-06 | 588 | 158 | 13 | 38580884 |
| Pubmed | RPL34 ZSCAN5A XBP1 SRCIN1 NCOR1 EHBP1L1 EXOC3L4 AMOTL1 ZNF516 EIF2B5 TAOK1 CEP131 MTCL1 ARHGAP19 | 3.51e-06 | 689 | 158 | 14 | 36543142 | |
| Pubmed | RPL34 H2AC21 MINDY2 HNRNPC H2AC6 H2AC20 CELSR3 H2AC1 KIAA1217 MDC1 H2AX H2AJ | 4.39e-06 | 513 | 158 | 12 | 25798074 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | PRUNE2 JCAD SPATA31E1 TRIP12 HNRNPC MAP3K1 NCOR1 USF3 TOB1 MDC1 SPRTN | 4.80e-06 | 430 | 158 | 11 | 35044719 |
| Pubmed | Gestational stress induces the unfolded protein response, resulting in heart defects. | 4.81e-06 | 25 | 158 | 4 | 27436040 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | FOXO3 CLASP1 SRP54 SLU7 DAXX KANK2 HNRNPC MAP3K1 RUSC2 STXBP3 UBR5 KIAA1217 EIF2B5 CEP41 CRYBG1 ALYREF ESPL1 | 5.53e-06 | 1038 | 158 | 17 | 26673895 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | H2AC21 NBEA CHD2 ARHGEF17 TRIP12 PRDM2 H2AC20 ARHGEF33 EXOC3L4 ALYREF MTCL1 C6 ELP4 RAI1 | 7.42e-06 | 736 | 158 | 14 | 29676528 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | UIMC1 CHERP TOPBP1 SLU7 CDCA8 TRIP12 HNRNPC ZNF512B RSBN1 NCOR1 H2AC20 MDC1 ALYREF CUX1 SDHB RAI1 | 7.89e-06 | 954 | 158 | 16 | 36373674 |
| Pubmed | UIMC1 TOPBP1 SRP54 KANK2 CDCA8 TRIP12 MIER1 KIF7 ZNF512B ZNF516 CEP131 RAI1 ZNF687 | 8.64e-06 | 645 | 158 | 13 | 25281560 | |
| Pubmed | 1.02e-05 | 30 | 158 | 4 | 16319397 | ||
| Pubmed | UIMC1 CLASP1 KANK2 CDCA8 HNRNPC RSBN1 ALYREF CEP131 ELP4 CUX1 ZNF687 | 1.15e-05 | 472 | 158 | 11 | 38943005 | |
| Pubmed | WIPF1 CLASP1 SRP54 SLU7 AHDC1 PRDM2 NCOR1 H2AC20 MAP7D1 KMT2D UBR5 ZNF516 ALYREF MZT2B CUX1 RAI1 ZNF687 | 1.21e-05 | 1103 | 158 | 17 | 34189442 | |
| Pubmed | 1.34e-05 | 32 | 158 | 4 | 30532072 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 1.40e-05 | 394 | 158 | 10 | 27248496 | |
| Pubmed | 1.70e-05 | 244 | 158 | 8 | 30349055 | ||
| Pubmed | PRUNE2 CTTNBP2 COL27A1 SYTL2 ZFP28 ARMCX2 PIKFYVE SHROOM4 USF3 LTN1 TAOK1 | 1.72e-05 | 493 | 158 | 11 | 15368895 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | CLASP1 NBEA CHD2 SORBS1 SRCIN1 TRIP12 SNX14 MAP7D1 TAOK1 RAI1 ZNF687 | 1.85e-05 | 497 | 158 | 11 | 36774506 |
| Pubmed | 1.96e-05 | 12 | 158 | 3 | 15525528 | ||
| Pubmed | DNA damage response protein TOPBP1 regulates X chromosome silencing in the mammalian germ line. | 2.05e-05 | 2 | 158 | 2 | 29114052 | |
| Pubmed | CircFOXO3 promotes glioblastoma progression by acting as a competing endogenous RNA for NFAT5. | 2.05e-05 | 2 | 158 | 2 | 31504797 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 31729360 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 27006389 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 32323858 | ||
| Pubmed | Expression and prognosis of FOXO3a and HIF-1α in nasopharyngeal carcinoma. | 2.05e-05 | 2 | 158 | 2 | 22209974 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 19176596 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 9852958 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 30153269 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 20021945 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 10790539 | ||
| Pubmed | H2AX prevents DNA breaks from progressing to chromosome breaks and translocations. | 2.05e-05 | 2 | 158 | 2 | 16427010 | |
| Pubmed | Structural insights into recognition of MDC1 by TopBP1 in DNA replication checkpoint control. | 2.05e-05 | 2 | 158 | 2 | 23891287 | |
| Pubmed | NOVA1 acts as an oncogene in melanoma via regulating FOXO3a expression. | 2.05e-05 | 2 | 158 | 2 | 29498217 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 35837403 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 37890842 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 23603388 | ||
| Pubmed | SRP54 mutations induce congenital neutropenia via dominant-negative effects on XBP1 splicing. | 2.05e-05 | 2 | 158 | 2 | 33227812 | |
| Pubmed | Hypoxia-responsive lncRNA G077640 promotes ESCC tumorigenesis via the H2AX-HIF1α-glycolysis axis. | 2.05e-05 | 2 | 158 | 2 | 37248865 | |
| Pubmed | CDCA8 promotes bladder cancer survival by stabilizing HIF1α expression under hypoxia. | 2.05e-05 | 2 | 158 | 2 | 37813876 | |
| Pubmed | Genetic investigation of FOXO3A requires special attention due to sequence homology with FOXO3B. | 2.05e-05 | 2 | 158 | 2 | 22588664 | |
| Pubmed | Activity of heme oxygenase-1 affects expression levels of hypoxia inducible factor-1 gene in vitro. | 2.05e-05 | 2 | 158 | 2 | 22613607 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 17967865 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 30982460 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 36608439 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 33795696 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 26694365 | ||
| Pubmed | XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway. | 2.05e-05 | 2 | 158 | 2 | 24670641 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 15805230 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 32975326 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 33207934 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 18799519 | ||
| Pubmed | Clustered DNA damage induces pan-nuclear H2AX phosphorylation mediated by ATM and DNA-PK. | 2.05e-05 | 2 | 158 | 2 | 23620287 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 36980257 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 23526997 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 33738869 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 19676145 | ||
| Pubmed | FoxO3 activation in hypoxic tubules prevents chronic kidney disease. | 2.05e-05 | 2 | 158 | 2 | 30912765 | |
| Pubmed | Recruitment of proteins to DNA double-strand breaks: MDC1 directly recruits RAP80. | 2.05e-05 | 2 | 158 | 2 | 21857162 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 22573121 | ||
| Pubmed | RBBP8NL PRDM2 NCOR1 MAP7D1 KMT2D UBR5 ZNF516 CEP131 CUX1 ZNF687 | 2.33e-05 | 418 | 158 | 10 | 34709266 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | UIMC1 TOPBP1 DAXX CHD2 CDCA8 TRIP12 MIER1 PRDM2 ZNF512B MDC1 CUX1 RAI1 | 2.38e-05 | 608 | 158 | 12 | 36089195 |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | FOXO3 EYA4 MIER1 H2AC18 NEK8 KIAA1217 ZNF516 H2AX DIXDC1 ELP4 | 2.42e-05 | 420 | 158 | 10 | 28065597 |
| Pubmed | 2.76e-05 | 77 | 158 | 5 | 12408966 | ||
| Pubmed | Precise characterization of human histones in the H2A gene family by top down mass spectrometry. | 3.23e-05 | 14 | 158 | 3 | 16457589 | |
| Interaction | LOC102724334 interactions | 9.27e-08 | 134 | 156 | 10 | int:LOC102724334 | |
| Interaction | H2AC4 interactions | H2AC21 DAXX CHD2 TRIP12 MIER1 HNRNPC H2AC6 H2AC18 H2AC20 KMT2D USF3 UBR5 H2AC1 H2AX H2AJ RAI1 ZNF687 | 4.20e-07 | 506 | 156 | 17 | int:H2AC4 |
| Interaction | H2BC3 interactions | H2AC21 DAXX TRIP12 HNRNPC H2AC6 H2AC18 H2AC20 KMT2D H2AC1 MDC1 H2AX H2AJ SPRTN CUX1 RAI1 | 6.42e-07 | 406 | 156 | 15 | int:H2BC3 |
| Interaction | H2AC1 interactions | 1.28e-06 | 71 | 156 | 7 | int:H2AC1 | |
| Interaction | H2AC13 interactions | 1.86e-06 | 75 | 156 | 7 | int:H2AC13 | |
| Interaction | H2BC21 interactions | UIMC1 BRPF3 H2AC21 SLU7 DAXX CDCA8 TRIP12 PRDM2 H2AC6 H2AC18 H2AC20 USF3 H2AC1 MDC1 H2AX CRYBG1 H2AJ RAI1 ZNF687 | 1.93e-06 | 696 | 156 | 19 | int:H2BC21 |
| Interaction | H2BC8 interactions | UIMC1 TOPBP1 H2AC21 SLU7 CDCA8 TRIP12 MIER1 ZNF512B H2AC6 H2AC18 MDC1 H2AX ALYREF SPRTN CUX1 RAI1 ZNF687 | 2.48e-06 | 576 | 156 | 17 | int:H2BC8 |
| Interaction | H2AC12 interactions | 3.83e-06 | 118 | 156 | 8 | int:H2AC12 | |
| Interaction | ASF1A interactions | SLU7 CDCA8 PRDM2 ZNF512B NCOR1 KMT2D MDC1 ZNF516 CUX1 RAI1 ZNF687 | 3.95e-06 | 249 | 156 | 11 | int:ASF1A |
| Interaction | H2AJ interactions | 6.62e-06 | 127 | 156 | 8 | int:H2AJ | |
| Interaction | H2BC18 interactions | 1.15e-05 | 180 | 156 | 9 | int:H2BC18 | |
| Interaction | H2BC17 interactions | 1.36e-05 | 140 | 156 | 8 | int:H2BC17 | |
| Interaction | TRIM36 interactions | 1.66e-05 | 144 | 156 | 8 | int:TRIM36 | |
| Interaction | H2BC15 interactions | 1.66e-05 | 144 | 156 | 8 | int:H2BC15 | |
| Interaction | H3-3A interactions | UIMC1 TOPBP1 DAXX CHD2 CDCA8 TRIP12 HNRNPC PRDM2 ZNF512B H2AC6 H2AC18 H2AC20 KMT2D MDC1 H2AX H2AJ CUX1 RAI1 | 2.07e-05 | 749 | 156 | 18 | int:H3-3A |
| Interaction | H3C1 interactions | UIMC1 CHERP H2AC21 DAXX CDCA8 TRIP12 PRDM2 ZNF512B PIKFYVE RSBN1 NCOR1 H2AC6 H2AC18 H2AC20 MAP7D1 KMT2D MDC1 H2AX H2AJ CUX1 | 2.20e-05 | 901 | 156 | 20 | int:H3C1 |
| Interaction | DYRK1A interactions | JCAD CCDC8 DSCAM MYO1E ENPP2 ARHGEF17 KANK2 TRIP12 LRP1B MAP3K1 KMT2D KIAA1217 EIF2B5 H2AX CEP131 | 2.62e-05 | 552 | 156 | 15 | int:DYRK1A |
| Interaction | NUP43 interactions | DSCAM SZT2 TOPBP1 CDCA8 TRIP12 AHDC1 PRDM2 RSBN1 NCOR1 H2AC18 KMT2D UBR5 MDC1 EIF2B5 ELP4 ZNF687 | 2.88e-05 | 625 | 156 | 16 | int:NUP43 |
| Interaction | H3-5 interactions | 2.99e-05 | 114 | 156 | 7 | int:H3-5 | |
| Interaction | DYNLL2 interactions | JCAD CTTNBP2 ZSCAN5A THAP10 KANK2 RSBN1 AMOTL1 MTCL1 CEP170B MOB4 | 3.99e-05 | 263 | 156 | 10 | int:DYNLL2 |
| Interaction | H2BC9 interactions | HIF1A ENPP2 H2AC21 KIF7 H2AC18 H2AC20 USF3 MDC1 CEP41 H2AX SPRTN RAI1 RAPGEFL1 | 4.54e-05 | 446 | 156 | 13 | int:H2BC9 |
| Interaction | H3-4 interactions | BRPF3 H2AC21 DAXX MIER1 AHDC1 PRDM2 H2AC6 H2AC18 H2AC20 USF3 ZNF516 H2AX H2AJ | 4.75e-05 | 448 | 156 | 13 | int:H3-4 |
| Interaction | CAMSAP2 interactions | 5.24e-05 | 169 | 156 | 8 | int:CAMSAP2 | |
| Interaction | H2BC5 interactions | MYO1E H2AC21 H2AC6 H2AC18 H2AC20 USF3 PTPRF H2AC1 H2AX H2AJ SPRTN | 5.57e-05 | 331 | 156 | 11 | int:H2BC5 |
| Interaction | TOP3B interactions | FOXO3 MYO1E SZT2 POLE H2AC21 STK11IP KANK2 AHDC1 PCNX2 PIKFYVE NCOR1 EHBP1L1 KMT2D CELSR3 PTPRF CELSR2 SGSM2 NEK8 MDC1 ZNF516 CEP131 ESPL1 ADAT1 CEP170B RAI1 ZNF687 | 6.10e-05 | 1470 | 156 | 26 | int:TOP3B |
| Interaction | H2BC26 interactions | 9.17e-05 | 183 | 156 | 8 | int:H2BC26 | |
| Interaction | H2BC11 interactions | 1.03e-04 | 186 | 156 | 8 | int:H2BC11 | |
| Interaction | PYHIN1 interactions | RPL34 CHERP SLU7 DAXX UBR5 MDC1 H2AX CRYBG1 RAI1 HERC5 ZNF687 | 1.12e-04 | 358 | 156 | 11 | int:PYHIN1 |
| Interaction | RNF168 interactions | 1.14e-04 | 98 | 156 | 6 | int:RNF168 | |
| Interaction | SENP3 interactions | HIF1A DAXX CDCA8 TRIP12 RSBN1 H2AC20 MAP7D1 KMT2D MTCL1 SPRTN | 1.22e-04 | 301 | 156 | 10 | int:SENP3 |
| Interaction | H2AC6 interactions | 1.28e-04 | 100 | 156 | 6 | int:H2AC6 | |
| Interaction | HDAC2 interactions | FOXS1 CCDC8 HIF1A SRA1 DAXX MIER1 HNRNPC PPM1H ZNF512B NCOR1 LIMK1 H2AC20 H2AC1 ZNF516 H2AX ESPL1 RAI1 ZNF687 | 1.32e-04 | 865 | 156 | 18 | int:HDAC2 |
| Interaction | H2AC14 interactions | 1.32e-04 | 144 | 156 | 7 | int:H2AC14 | |
| Interaction | ZBTB7B interactions | MYO1E COL27A1 KIF7 H2AC20 MAP7D1 STXBP3 ZNF516 ALYREF NFAT5 CEP170B CUX1 | 1.36e-04 | 366 | 156 | 11 | int:ZBTB7B |
| Interaction | NCOA1 interactions | 1.44e-04 | 146 | 156 | 7 | int:NCOA1 | |
| Interaction | BICD1 interactions | 1.48e-04 | 250 | 156 | 9 | int:BICD1 | |
| Interaction | LATS1 interactions | JCAD CHERP SLU7 CHD2 KIF7 H2AC6 LIMK1 KIAA1217 AMOTL1 TAOK1 CEP131 MOB4 | 1.67e-04 | 440 | 156 | 12 | int:LATS1 |
| Interaction | CENPA interactions | POLE CDCA8 TRIP12 PRDM2 ZNF512B RSBN1 H2AC20 H2AX ALYREF CUX1 RAI1 | 1.76e-04 | 377 | 156 | 11 | int:CENPA |
| Interaction | H2AC7 interactions | 1.85e-04 | 107 | 156 | 6 | int:H2AC7 | |
| Interaction | PARP1 interactions | UIMC1 CCDC8 HIF1A CHERP MYO1E POLE TOPBP1 H2AC21 SLU7 DAXX KANK2 CDCA8 TRIP12 PRDM2 ZNF512B RSBN1 H2AC6 H2AC18 H2AX H2AJ SPRTN CUX1 RAI1 | 2.03e-04 | 1316 | 156 | 23 | int:PARP1 |
| Interaction | BRCA2 interactions | UIMC1 EYA4 POLE TOPBP1 DAXX AHDC1 HNRNPC MDC1 H2AX CEP131 REV1 | 2.06e-04 | 384 | 156 | 11 | int:BRCA2 |
| Interaction | PRKRA interactions | RPL34 CHERP ZFP28 TRIP12 HNRNPC RSBN1 H2AC20 MAP7D1 MDC1 H2AX HERC5 | 2.92e-04 | 400 | 156 | 11 | int:PRKRA |
| Interaction | SFN interactions | FOXO3 JCAD HIF1A RPL34 CLASP1 SORBS1 ARHGEF17 TRIP12 RUSC2 MAP7D1 NEK8 TRIM62 CEP131 CEP170B ARHGAP19 | 3.20e-04 | 692 | 156 | 15 | int:SFN |
| GeneFamily | Histones | 1.80e-06 | 116 | 90 | 7 | 864 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 7.33e-05 | 3 | 90 | 2 | 913 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 7.33e-05 | 3 | 90 | 2 | 1189 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP | 2.82e-06 | 196 | 156 | 9 | M9867 | |
| Coexpression | BENPORATH_NANOG_TARGETS | FOXO3 UIMC1 ENPP2 CHD2 SORBS1 MINDY2 STK11IP NCOR1 H2AC18 CEPT1 UBR5 KIAA1217 AMOTL1 ZNF516 H2AX TMEM108 H2AJ NFAT5 RAI1 | 7.02e-06 | 988 | 156 | 19 | M6616 |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN | 2.66e-05 | 199 | 156 | 8 | M7319 | |
| Coexpression | GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN | 2.76e-05 | 200 | 156 | 8 | M6053 | |
| Coexpression | GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY3_POST_IMMUNIZATION_DN | 2.76e-05 | 200 | 156 | 8 | M9275 | |
| Coexpression | BENPORATH_SOX2_TARGETS | UIMC1 ENPP2 HMOX1 MINDY2 HNRNPC H2AC18 UBR5 MDC1 AMOTL1 ZNF516 CEP41 H2AX TMEM108 CEP131 H2AJ | 3.46e-05 | 734 | 156 | 15 | M3835 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | EYA4 SYTL2 NBEA CHD2 EPS8L1 ANKRD36B SGSM2 KIAA1217 RAI1 RAPGEFL1 | 8.72e-10 | 179 | 157 | 10 | 6e965e424eebef50f0202cff75f458be395cfca1 |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.27e-06 | 168 | 157 | 7 | 45ccc0cb42d21f4853190e8e9ed9a54aefefe738 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.49e-06 | 192 | 157 | 7 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-06 | 197 | 157 | 7 | 8786125b669d5d0b15e12df0ade6b319f09f7333 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.71e-06 | 198 | 157 | 7 | 3575620db5aeaeb0bdcd7a8ff65c43abd3fa13e4 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.16e-06 | 200 | 157 | 7 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.16e-06 | 200 | 157 | 7 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.16e-06 | 200 | 157 | 7 | 4c3c11dd5e71ebc3d62264eeaeb71a850b149779 | |
| ToppCell | PND01-03-samps-Myeloid-Macrophage-CD163+_Macrophage|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.23e-05 | 160 | 157 | 6 | 4480a7d6bd48d06b4e5196faac868f31ab7ed3ad | |
| ToppCell | 367C-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.57e-05 | 164 | 157 | 6 | 1aff83fc73b4e41e6f0d4b04dbca153bcc7a3518 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 2.75e-05 | 166 | 157 | 6 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | Lymphoid-Lymphoid-B_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 3.35e-05 | 172 | 157 | 6 | f39822afcc35f0fbf68b8ffd1894e4b6c8d7a80c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.46e-05 | 173 | 157 | 6 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.58e-05 | 174 | 157 | 6 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.58e-05 | 174 | 157 | 6 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | wk_15-18-Epithelial-PNS-Schwann_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.93e-05 | 177 | 157 | 6 | 5357359e6c2161a37f39a6b3b78449f5cbc327d1 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.93e-05 | 177 | 157 | 6 | a4c001a8e44142babf9f24dfe6f7b73a70b11b16 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.93e-05 | 177 | 157 | 6 | 363e07b0f347f3716d530a28ead854b98e27d37c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.06e-05 | 178 | 157 | 6 | c20f050344a2e120e685e2a7fe36c6dfc1dc37b6 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.32e-05 | 180 | 157 | 6 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | critical-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.46e-05 | 181 | 157 | 6 | f0d81ae74d3f32979624a94b2ef93774831a7970 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-05 | 182 | 157 | 6 | bc6a120dedc813c58baac1428c39851a07b71ba7 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-05 | 182 | 157 | 6 | 0fc45214f0b0766f69be6eff69cc4bec574023aa | |
| ToppCell | Lymphoid-B_cells_(cycle)|World / shred on cell class and cell subclass (v4) | 4.62e-05 | 111 | 157 | 5 | df23af931ce0258ce97d6b4c7125ae1ab16a7eaa | |
| ToppCell | metastatic_Brain-Endothelial_cells-Stalk-like_ECs|metastatic_Brain / Location, Cell class and cell subclass | 5.03e-05 | 185 | 157 | 6 | ad52970e88e8947ef256095bd4b40229b912d58a | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.03e-05 | 185 | 157 | 6 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | 5.50e-05 | 188 | 157 | 6 | b240ea20750ffb825cb5fe41d06c632233406ab6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.50e-05 | 188 | 157 | 6 | 4154f4787483c7e076e87a187733a9f666742c3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.67e-05 | 189 | 157 | 6 | 90aae7e806882bebfad78a78e9a16cf56af3ecd4 | |
| ToppCell | (02)_Cycling_Basal_(regeneration)|World / shred by cell type and Timepoint | 5.83e-05 | 190 | 157 | 6 | 53f017a11ca5ebe9025558e12cedc409cab2e5aa | |
| ToppCell | Endothelial-D_(cycle)|World / shred on cell class and cell subclass (v4) | 6.01e-05 | 191 | 157 | 6 | 49a4d8f181558e3be9527a8ff9a178f3bb01323c | |
| ToppCell | Endothelial-Endothelial-D_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 6.01e-05 | 191 | 157 | 6 | a3c5a913a99f17633c140ec9ece81b73e59e0715 | |
| ToppCell | control-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.01e-05 | 191 | 157 | 6 | afebdc59a1f884ce3f2f5fe040e16b0e95e4e7c5 | |
| ToppCell | facs-Thymus-Flowthrough-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.18e-05 | 192 | 157 | 6 | 7a0ef1702d6538e5611cfdc633d8558f9523845c | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.18e-05 | 192 | 157 | 6 | 6bba80887d6f64cf913a5c22f62baaddda417ce0 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.18e-05 | 192 | 157 | 6 | 6806a1a9fe00395dc1abc3e0124b4261dc701f31 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.18e-05 | 192 | 157 | 6 | 05043fb75319b64f5ed7aee6a232309dcae891b8 | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 194 | 157 | 6 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | 356C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 6.55e-05 | 194 | 157 | 6 | 11ff53a748160570d2908ea9eb9779c038e5b676 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-05 | 194 | 157 | 6 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-05 | 194 | 157 | 6 | 46070fbb0ee0eb9e1801c43b73a15707471056dc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-05 | 194 | 157 | 6 | abacb6a8d7a9003f2f6c2be0305507f1c1c50347 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 194 | 157 | 6 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 6.74e-05 | 195 | 157 | 6 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Pericytes|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.33e-05 | 198 | 157 | 6 | 5e274c5597d8720290d452465f0bd40637cb3f27 | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.33e-05 | 198 | 157 | 6 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 7.53e-05 | 199 | 157 | 6 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 7.53e-05 | 199 | 157 | 6 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | Macroglial-Oligodendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.75e-05 | 200 | 157 | 6 | 4dbac2f2587e87ca5a0622f50439bb5447e93c7f | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.75e-05 | 200 | 157 | 6 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.75e-05 | 200 | 157 | 6 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.75e-05 | 200 | 157 | 6 | 36de49593cf6ff1c9229fcceb150c1d68658a360 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.75e-05 | 200 | 157 | 6 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.75e-05 | 200 | 157 | 6 | 26b989e30bbbaf30904ced03f6aae3dea25c732c | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.75e-05 | 200 | 157 | 6 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 7.75e-05 | 200 | 157 | 6 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid-Megakaryocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.75e-05 | 200 | 157 | 6 | 0d76b006d8e8b32174e65e400acd0674354b962c | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.75e-05 | 200 | 157 | 6 | cc8368665bc6bb7c4f39632ccff07ceaa98a7b65 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.75e-05 | 200 | 157 | 6 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.75e-05 | 200 | 157 | 6 | 1314664c1721e9ecb1e2c3482a039044b0fe50a9 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.75e-05 | 200 | 157 | 6 | 8b229f095fc113aecfc94b64862a9e0fdcc363ce | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 7.75e-05 | 200 | 157 | 6 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.75e-05 | 200 | 157 | 6 | 272909f4354f3ae22e2b2f8f35970e6b0e92cfe2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.75e-05 | 200 | 157 | 6 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 7.75e-05 | 200 | 157 | 6 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.75e-05 | 200 | 157 | 6 | 5f75a9b8bcd49d9bbb1e9ce2de730eaec96369ca | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.75e-05 | 200 | 157 | 6 | 77631c471cc5d453a749784f838cfa6408caf09b | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.75e-05 | 200 | 157 | 6 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D231|Adult / Lineage, Cell type, age group and donor | 1.05e-04 | 132 | 157 | 5 | 8d30b71776f5f6da55dc78e0c5cb27be460004e3 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD4+_T_cell_(ISG_high)|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.29e-04 | 138 | 157 | 5 | 97f5dc17522462133e582b508ad0ef036e656872 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-CD4-positive,_alpha-beta_memory_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.34e-04 | 139 | 157 | 5 | 7c02caed5b9baf233bd6fb9a453708b3e157c790 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.53e-04 | 143 | 157 | 5 | 92ddc3e3f6ba78dd9daeb272c12503ec2650a874 | |
| Computational | Genes in the cancer module 89. | 1.87e-04 | 14 | 89 | 3 | MODULE_89 | |
| Computational | Genes in the cancer module 203. | 2.84e-04 | 16 | 89 | 3 | MODULE_203 | |
| Computational | Genes in the cancer module 90. | 3.43e-04 | 17 | 89 | 3 | MODULE_90 | |
| Computational | Chromatin and nucleosomes. | 4.09e-04 | 18 | 89 | 3 | MODULE_552 | |
| Disease | dermoid cyst of ovary (implicated_via_orthology) | 2.43e-05 | 2 | 146 | 2 | DOID:5117 (implicated_via_orthology) | |
| Disease | Autism Spectrum Disorders | 6.61e-05 | 85 | 146 | 5 | C1510586 | |
| Disease | mental or behavioural disorder, attempted suicide | 2.41e-04 | 5 | 146 | 2 | EFO_0000677, EFO_0004321 | |
| Disease | coronary artery disease | ANKRD31 JCAD DSCAM CHD2 KANK2 AHDC1 HNRNPC F13A1 MAP3K1 RSBN1 EHBP1L1 CELSR2 KIAA1217 LINGO4 NFAT5 RAI1 | 2.92e-04 | 1194 | 146 | 16 | EFO_0001645 |
| Disease | Familial aplasia of the vermis | 4.37e-04 | 30 | 146 | 3 | C0431399 | |
| Disease | OROFACIODIGITAL SYNDROME VI | 5.02e-04 | 7 | 146 | 2 | C2745997 | |
| Disease | retinal ischemia (biomarker_via_orthology) | 5.02e-04 | 7 | 146 | 2 | DOID:12510 (biomarker_via_orthology) | |
| Disease | pulse pressure measurement | FOXO3 JCAD BRPF3 WIPF1 DSCAM MYO1E ENPP2 COL27A1 NBEA CHD2 AHDC1 H2AC6 LIMK1 WASF2 KIAA1217 ZNF516 NFAT5 | 5.44e-04 | 1392 | 146 | 17 | EFO_0005763 |
| Disease | Chronic Obstructive Airway Disease | 5.81e-04 | 33 | 146 | 3 | C0024117 | |
| Disease | Chronic Airflow Obstruction | 5.81e-04 | 33 | 146 | 3 | C1527303 | |
| Disease | Glioblastoma | 6.48e-04 | 79 | 146 | 4 | C0017636 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 6.54e-04 | 139 | 146 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | tumor necrosis factor receptor superfamily member 19L measurement | 6.68e-04 | 8 | 146 | 2 | EFO_0008309 | |
| Disease | Thyroid Gland Follicular Adenoma | 6.92e-04 | 35 | 146 | 3 | C0151468 | |
| Disease | stomach cancer (is_marker_for) | 7.20e-04 | 142 | 146 | 5 | DOID:10534 (is_marker_for) | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 7.67e-04 | 144 | 146 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | Thyroid Neoplasm | 8.15e-04 | 37 | 146 | 3 | C0040136 | |
| Disease | transmembrane protein 9 measurement | 8.56e-04 | 9 | 146 | 2 | EFO_0803190 | |
| Disease | triglycerides to total lipids in large VLDL percentage | 9.52e-04 | 39 | 146 | 3 | EFO_0022332 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 1.30e-03 | 11 | 146 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | Thyroid carcinoma | 1.35e-03 | 44 | 146 | 3 | C0549473 | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 1.55e-03 | 12 | 146 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 1.65e-03 | 171 | 146 | 5 | DOID:9352 (is_implicated_in) | |
| Disease | myocardial infarction | 1.85e-03 | 350 | 146 | 7 | EFO_0000612 | |
| Disease | glucose-dependent insulinotropic peptide measurement, glucose tolerance test | 2.13e-03 | 14 | 146 | 2 | EFO_0004307, EFO_0008464 | |
| Disease | susceptibility to bacterial meningitis measurement | 2.20e-03 | 52 | 146 | 3 | EFO_0008411 | |
| Disease | free cholesterol measurement | 2.44e-03 | 113 | 146 | 4 | EFO_0008591 | |
| Disease | Hepatitis | 2.45e-03 | 15 | 146 | 2 | C0019158 | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 2.45e-03 | 15 | 146 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | immature platelet fraction | 2.52e-03 | 114 | 146 | 4 | EFO_0009187 | |
| Disease | Malignant neoplasm of breast | HIF1A WNT10B XBP1 H2AC21 GRIK3 SORBS1 HMOX1 MAP3K1 NCOR1 KMT2D H2AX CYB5R4 CUX1 | 2.68e-03 | 1074 | 146 | 13 | C0006142 |
| Disease | birth weight, parental genotype effect measurement | 2.73e-03 | 192 | 146 | 5 | EFO_0004344, EFO_0005939 | |
| Disease | age at menarche | 2.89e-03 | 594 | 146 | 9 | EFO_0004703 | |
| Disease | blood osmolality measurement | 3.00e-03 | 58 | 146 | 3 | EFO_0007967 | |
| Disease | Benign neoplasm of stomach | 3.15e-03 | 17 | 146 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 3.15e-03 | 17 | 146 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 3.15e-03 | 17 | 146 | 2 | C0154060 | |
| Disease | IGF-1 measurement, IGFBP-3 measurement | 3.15e-03 | 17 | 146 | 2 | EFO_0004626, EFO_0004627 | |
| Disease | Malignant neoplasm of endometrium | 3.53e-03 | 18 | 146 | 2 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 3.53e-03 | 18 | 146 | 2 | C0346191 | |
| Disease | diet measurement, HOMA-B | 3.93e-03 | 19 | 146 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | level of Phosphatidylethanolamine (18:0_20:4) in blood serum | 3.93e-03 | 19 | 146 | 2 | OBA_2045140 | |
| Disease | Familial aplasia of the vermis | 4.36e-03 | 20 | 146 | 2 | cv:C0431399 | |
| Disease | serum IgG glycosylation measurement | 4.63e-03 | 523 | 146 | 8 | EFO_0005193 | |
| Disease | Stomach Carcinoma | 4.80e-03 | 21 | 146 | 2 | C0699791 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PTNVGSKAFGRRRRD | 111 | P06881 | |
| KNLSTPGTRVQARGR | 1501 | Q68DN1 | |
| AQGSRRTSSRKEPNA | 26 | Q17RC7 | |
| PKRRNGSEGNITTRI | 646 | P39880 | |
| FKPGSSRTVNQGRDS | 126 | Q155Q3 | |
| KSRSSRAGLQFPVGR | 16 | Q8IUE6 | |
| KSRSSRAGLQFPVGR | 16 | Q16777 | |
| KSRSSRAGLQFPVGR | 16 | Q7L7L0 | |
| KSRSSRAGLQFPVGR | 16 | Q9BTM1 | |
| SSGGRAPIKAERAAQ | 731 | A8MVX0 | |
| NSSGRESKVPGARSA | 331 | Q9BYV8 | |
| RKSRQNAEGRRSPSP | 6 | Q9ULD4 | |
| QKSRTEGRPTVNRAN | 226 | Q8IY63 | |
| RGNRKAVKSPQRSSS | 161 | Q6IQ19 | |
| KDGQIRGTVSSQRRP | 621 | Q8N2N9 | |
| SLGGRRKRNVNTAPQ | 166 | Q9HCU4 | |
| QSVLFQSSSKPGRGR | 1221 | Q5TGY3 | |
| GRSSGPQRAGSLKRE | 456 | Q9Y4F5 | |
| RSSGEQQNKGRIVSP | 516 | Q9UER7 | |
| PKNRAVAGTGARARA | 41 | Q7L311 | |
| SRSAVQAKRADSPGR | 376 | Q9BUB4 | |
| GKRNGRVSIRDSPAN | 76 | Q08708 | |
| EQAQKPSFQSGGRRR | 81 | P0DJD4 | |
| SSPQKEGRVSQRARV | 1191 | Q7Z5J4 | |
| ATPQAKERARGQAGR | 186 | Q96NA2 | |
| QDPFQKGLRAGSRSR | 1776 | Q9Y4B5 | |
| KQRTKGNLRPSNSGR | 6 | O94822 | |
| QARTRAKGPGGTSRA | 431 | Q96PE2 | |
| KRGNRKTSSQQSPTG | 1616 | Q8N7Z5 | |
| SVLPAGNRGARKASR | 41 | Q460N3 | |
| RAVVPSKRQRVSGNT | 151 | P07910 | |
| RDGRNPTILRNKTSG | 1806 | Q9NZR2 | |
| PSRAKISGQNSSVRG | 376 | Q96JY0 | |
| SEPTSQATRGRKNRS | 1221 | Q14676 | |
| QATRGRTNRSSVKTP | 1431 | Q14676 | |
| IKRQRAAGNPGSLAA | 1721 | Q14676 | |
| DTQSRTASPNRAGKG | 661 | Q16665 | |
| NPKGRQAARTGTRAG | 26 | Q9P266 | |
| QAASASQPGELRGRK | 3521 | Q2LD37 | |
| GKRSSRANTVTPAVG | 161 | Q53HL2 | |
| RSGKSGAQQGLAPRS | 491 | Q6ZUT6 | |
| VVVSRANKRSGAGPG | 11 | Q13144 | |
| KSRSSRAGLQFPVGR | 16 | P16104 | |
| ALGTTRKFQATGSRP | 41 | Q6P4F2 | |
| GTQRTGRRKGRSQSV | 1926 | A6NKB5 | |
| GRDAASQNLKRRPGS | 196 | C9JC47 | |
| NGRRGPSQRSKLGKS | 2136 | Q5H8C1 | |
| GVNRNRKTNGSIPET | 31 | H3BV12 | |
| PRSGGREANTKRSGV | 396 | Q8N3D4 | |
| RDAASQNLKRRPGSG | 201 | P0CG43 | |
| PGSRAVGGSKARVQA | 676 | Q2M1P5 | |
| NTRRGSRAPCKVQGL | 596 | Q86SG6 | |
| AGRVNTKVRSFGPLS | 171 | P54753 | |
| SGRGNPIKVSRVGSA | 251 | P00488 | |
| NEEQNSGTKRRGPRT | 171 | Q9H2C1 | |
| GSTPVRRRGASQLSQ | 2021 | Q07864 | |
| LQSSGRSQSKGRRGA | 11 | Q6NUT2 | |
| KSRSSRAGLQFPVGR | 16 | Q6FI13 | |
| SRGSVKDRTQQGFPT | 301 | O94916 | |
| RNGRSTAGKAAATQP | 11 | Q9UII4 | |
| RSPQALSNGTKGTRV | 486 | Q8NC74 | |
| AGKSPARNRSASITN | 296 | Q9Y2I7 | |
| ASQNLKRRPGSGTDG | 201 | P0CG42 | |
| AGGSGQPRKCSSRRN | 226 | A0A2Z4LIS9 | |
| DGKQARRTNSSSPLG | 136 | Q9Y6K0 | |
| SSGSKSRGRGRKNNP | 346 | O95677 | |
| EPSKTQGQKRSGRGR | 1306 | Q14674 | |
| RKGQEKRNSGPSRSR | 726 | Q8IWX8 | |
| SKVRSVLRPSQFGGQ | 101 | P13671 | |
| GSESGSPKRRGQRQL | 131 | O14647 | |
| LSRASVKRQPGFGQT | 1371 | Q8WZ74 | |
| PCRTRGSGQKNSRRK | 286 | Q9H972 | |
| GTGQTPAKQAVRFRA | 1776 | Q8IZC6 | |
| AQRRSNPPSRKGSGF | 221 | P08034 | |
| SRSAVTLPRNGRDQG | 311 | Q3KQU3 | |
| RQTGAEGTRGPAKAR | 116 | O43638 | |
| QLRPAGTAAAKTSRQ | 546 | Q63ZY3 | |
| LGDRAGSSPTNKTAR | 566 | Q9ULL0 | |
| SRAPGLRQRASNKVQ | 231 | P09601 | |
| KRRPRFPVNSNSNGG | 26 | P20849 | |
| DTSGSSVARRAPKRQ | 31 | Q96QF7 | |
| GSSVARRAPKRQASS | 61 | Q96QF7 | |
| GRRRGSQKSTDSPGA | 11 | Q9Y4K1 | |
| RGQRNTPASSKTFVG | 291 | Q9Y4K1 | |
| ASKSNVTSFQRRGPR | 21 | Q96EB1 | |
| GVNRNRKTNGSIPET | 31 | I6L899 | |
| GVNRNRKTNGSIPET | 31 | A6NCC3 | |
| SSQRNAGTGSRKRVG | 186 | Q9NYQ7 | |
| STVERGAGRGRPQAK | 201 | Q8TE68 | |
| KGRGPNVTDSLTNRS | 421 | Q13003 | |
| KSRSSRAGLQFPVGR | 16 | Q96QV6 | |
| KSRSSRAGLQFPVGR | 16 | Q93077 | |
| GTTGTAPGARARKQV | 461 | Q9H0W5 | |
| RNNTGGSTGLPRRKE | 241 | Q9UPN4 | |
| VPGTLGRIRSKFSNN | 386 | Q13822 | |
| RPSGDKNSGGNRVTA | 576 | Q6UY18 | |
| AKRRRVNSNGKESPG | 476 | Q8N108 | |
| RFNIKSRERSGGPVT | 1636 | Q13029 | |
| DPATSNGRIKQLRSG | 176 | P10586 | |
| GTRNRKVTITGTPAA | 466 | P51513 | |
| ASNKTRLSRTPGNRI | 16 | P49207 | |
| TKSQSGGRPVSRTRQ | 566 | Q96BN6 | |
| VQASAASPASKGRRS | 236 | Q13233 | |
| TTRRNAKAGPTARNR | 1731 | O60469 | |
| AGGSGQPRKCSSRRN | 141 | O43524 | |
| ASPSSGRQSGNSERK | 586 | Q8NBR6 | |
| QASTPRATGRGARKA | 751 | Q8N2Y8 | |
| SPRGVKRQRRSSSGG | 81 | Q5VWQ0 | |
| RGAPRGILKRNSSSS | 266 | Q9HCH5 | |
| ERAPGSDSGAQRQKR | 2491 | Q5T011 | |
| SRGTPNRERKQGEQS | 721 | Q8N1F8 | |
| RSEASANLGGVPSKR | 16 | P62341 | |
| FSKQPGRIQRVARGS | 396 | P61011 | |
| SKSRGRAGPDAVTLQ | 2701 | Q8WUY3 | |
| GTAVLRRNRPGTKAQ | 6 | Q9Y3A3 | |
| QRETTRTGSQPGRNI | 1586 | Q8NFP9 | |
| QATPRGRKTANSQGR | 566 | O75376 | |
| QEALRRQGSASGKAP | 106 | O43147 | |
| SSSTQTQGRRPRKNK | 181 | Q6ZNE9 | |
| NSRGSVSKSSRNIPR | 51 | Q5T5P2 | |
| SGGTRGRSIQNRRKS | 571 | Q9ULL8 | |
| GVRNSPQALRRTASG | 961 | Q7L7X3 | |
| PSRDQGSGRTSVKAL | 716 | Q6ZUB1 | |
| ASGGLPQARKRQRLT | 51 | P17861 | |
| APRSQQRVASGGRSK | 11 | Q7L1T6 | |
| NGSGAVSARQKPRAN | 506 | O00186 | |
| TPDNRGRSRAKVVSQ | 656 | Q7Z460 | |
| PNRRAAATTGQGKSS | 501 | Q92618 | |
| RPRSRNGLASKGQRG | 46 | Q8NHY6 | |
| RGSPVRQSFRKDSGS | 501 | Q9C0H9 | |
| SRVRTPTSQQKGSRG | 156 | B3KS81 | |
| SKGKSQNQSRTPRRG | 336 | B3KS81 | |
| GKPVAVTSNRGTGRA | 441 | Q9UBZ9 | |
| GAESPTRNSKLNRGS | 471 | Q9Y5W7 | |
| RNSSKRRSSLPNGEG | 116 | Q9ULR3 | |
| GRRGSSRPSKRQPDQ | 91 | A0A1B0GVG6 | |
| QTQAGGPRRSLLTKR | 26 | Q9HD15 | |
| QAGRKAARRGGSQQP | 1201 | Q9BX66 | |
| GNRGDALNLSSPKRS | 286 | Q9BUG6 | |
| RPRRVGAKFTGTNIA | 136 | O95391 | |
| PSKLARNESRSGSNR | 476 | O43516 | |
| SGSKIRQPERNRSGN | 1986 | Q68DE3 | |
| GREPSTSQVQKRARS | 406 | Q14CB8 | |
| KAFRGVNGSPRISVT | 341 | Q9H040 | |
| GRSNKVARTSPINLG | 196 | P50616 | |
| QRGSGLAGPKRSSVV | 281 | Q9Y6W5 | |
| LTRSENKAPRATGRN | 326 | Q96KM6 | |
| RAQGPGRKRRQSSDS | 1071 | Q8N1G0 | |
| SPGTRGRACNKTSRL | 326 | O00744 | |
| GAQRSQKERAGGSPS | 51 | Q8TDI7 | |
| PAGGQRSLQRRQSVS | 46 | Q9UHV5 | |
| TRPRAGKQAAASQIT | 131 | Q9P2Z0 | |
| SRGAQTAAATAPRIK | 26 | P21912 | |
| GSLRRSQRNTAGAQP | 11 | Q14669 | |
| KPQGQRTSLSRSGCN | 1086 | Q92547 | |
| AASRKGSIQIQPSRG | 371 | Q9BVG3 | |
| VQPGSRTRTKAGRGR | 701 | Q96RL1 | |
| RGRGAGRNSKQQLSA | 226 | Q86V81 | |
| KLNSNSGAGRTSRPG | 91 | O95071 | |
| SRSKEGQRGRNPSST | 191 | Q6UXF1 | |
| SPARGRIQFSGRKST | 26 | Q8TCH9 | |
| GVNRNRKTNGSIPET | 31 | F8WBI6 | |
| ARSRIKQGRSSSFPG | 1296 | O14686 | |
| SGEAGSSARQKPVLR | 281 | P53667 | |
| PDQGAAGVRRQTTSR | 1021 | Q12965 | |
| SVPETRGRNKGSAAL | 101 | Q6NZ67 | |
| SNGRKRNPEAGVATT | 356 | P16519 |